P

Inventor

YLA-HERTTUALA SEPPO

FI12 patents
⚠️ This page may combine multiple inventors who share the name “YLA-HERTTUALA SEPPO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARK THERAPEUTICS LTD

4 patents
US6579855B1Jun 17, 2003

Adenovirus-mediated gene therapy

ARK THERAPEUTICS LTD19 citations82
US7393677B2Jul 1, 2008

Avidin-pseudotyped viral vectors and their use

ARK THERAPEUTICS LTD3 citations51
US7320679B2Jan 22, 2008

Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia

ARK THERAPEUTICS LTD1 citations49
US7208291B2Apr 24, 2007

Nucleic acids encoding biotin-binding receptors

ARK THERAPEUTICS LTD0 citations36

TRIZELL LTD

4 patents
US11261416B2Mar 1, 2022

Fixed-bed bioreactor with constant-flow pump / tubing system

TRIZELL LTD2 citations66
US11242504B2Feb 8, 2022

Aseptic bioreactor sampling system

TRIZELL LTD2 citations64
US12152281B2Nov 26, 2024

Gene therapy vector contamination assay

TRIZELL LTD0 citations43
US10829785B2Nov 10, 2020

Nucleic acid application primers

TRIZELL LTD0 citations43

LUDWIG INST CANCER RES

1 patent
US6958147B1Oct 25, 2005

Use of VEGF-C to prevent restenosis

LUDWIG INST CANCER RES41 citations89

VEGENICS PTY LTD

1 patent
US8025886B2Sep 27, 2011

Modified VEGF-A with improved angiogenic properties

VEGENICS PTY LTD2 citations54

LUDWIG INSTITIUTE FOR CANCER R

1 patent
US6974816B2Dec 13, 2005

Combination for the treatment of endothelial damage

LUDWIG INSTITIUTE FOR CANCER R0 citations43

TOIVANEN PYRY

1 patent
US8188039B2May 29, 2012

VEGF-D mutants and their use

TOIVANEN PYRY0 citations34